{"id":"W4386800579","doi":"10.1093/neuonc/noad174","title":"Indoximod-based chemo-immunotherapy for pediatric brain tumors: A first-in-children phase I trial","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":42,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; Cannonball Kids' cancer Foundation; Alex's Lemonade Stand Foundation for Childhood Cancer","keywords":"Medicine; Temozolomide; Internal medicine; Immunotherapy; Oncology; Gastroenterology; Radiation therapy; Chemotherapy; Glioma; Cancer; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00102733,0.001269326,0.001781726,0.0002524766,0.0002939165,0.0007052188,0.0006727881,0.001004565,0.00192507],"category_scores_gemma":[0.0005381497,0.0003147439,0.001035485,0.0003306324,0.0006309698,0.0004305979,0.0002801853,0.002588335,0.0004114982],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001300781,"about_ca_system_score_gemma":0.002028586,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001416495,"about_ca_topic_score_gemma":0.004088508,"domain_scores_codex":[0.9997271,0.0001219756,0.00001577507,0.0000433787,0.00003142401,0.00006031606],"domain_scores_gemma":[0.9994122,0.00009386851,0.0001596157,0.00004021111,0.00004385487,0.0002502755],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5189874,0.04412756,0.02995845,0.005404038,0.005827102,0.001589744,0.0009274994,0.00724401,0.07736658,0.001537014,0.02372012,0.2833105],"study_design_scores_gemma":[0.6071817,0.3237928,0.02615909,0.0002972,0.001936886,0.002169387,0.0001212177,0.001929361,0.01619115,0.000377561,0.01979882,0.00004482169],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9803362,0.01136412,0.0007859764,0.0008436623,0.0001518541,0.001965204,0.00225287,0.0001223397,0.00217783],"genre_scores_gemma":[0.9742804,0.01031498,0.003761422,0.001183235,0.0002328009,0.003760823,0.003754441,0.00005030158,0.002661604],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00192507,"threshold_uncertainty_score":0.009437859,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03334143304673527,"score_gpt":0.3250736354232843,"score_spread":0.291732202376549,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}